SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® ...
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, announced today that a team of globally ...
NanoString's Prosigna tests works with its nCounter analyzer.--Courtesy of NanoString NanoString ($NSTG) is working to expand the adoption of its breast cancer ...
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced it has launched ...
NanoString Technologies, Inc., has announced the availability of the nCounter® Rat miRNA Expression Assay Kit for use on its nCounter Analysis System. “We are pleased to offer these researchers a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results